首页 > 市场调查报告书 > 製药

再生医学细胞疗法

市场调查报告书

商品编码

1904895

干细胞疗法市场规模、份额和成长分析（治疗方法、类型、来源、给药途径、技术、应用和地区划分）—2026-2033年产业预测

Stem Cell Therapy Market Size, Share, and Growth Analysis, By Therapy, By Type, By Source, By Route of Administration, By Technology, By Application, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 197 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球干细胞治疗市场规模预计在 2024 年达到 3.6962 亿美元，从 2025 年的 4.3874 亿美元增长到 2033 年的 17.2907 亿美元，在预测期（2026-2033 年）内复合年增长率为 18.7%。

全球干细胞治疗市场正经历显着扩张，这主要得益于慢性疾病发病率的上升以及干细胞疗法作为高效、以疗效为导向的治疗方法的广泛应用。监管支持的加强和消费者对再生医学日益增长的需求也推动了市场发展。利用间质干细胞（MSCs）和诱导性多功能干细胞（iPSCs）的细胞疗法尤其引人注目，并已被应用于包括神经系统疾病、心臟病和肌肉骨骼疾病在内的多个治疗领域。然而，市场成长仍面临诸多挑战，例如与研发、临床试验和监管核准相关的高昂前期成本，以及商业化方面的技术难题。

全球干细胞治疗市场按类型、治疗方法、来源、给药途径、技术、应用、最终用户和地区进行细分。按类型划分，干细胞治疗市场可分为全能干细胞、多能干细胞、多功能能干细胞、单能干细胞和其他类型。治疗方法，异体干细胞治疗和自体干细胞疗法。依来源划分，干细胞治疗市场可分为成体干细胞、胚胎干细胞、间质干细胞（MSCs）及诱导性多功能干细胞（iPS）。依给药途径划分，干细胞治疗市场可分为静脉注射、关节内注射、鞘内注射、皮内注射及其他途径。依技术划分，干细胞治疗市场可分为细胞采集（骨髓采集、脐带血采集、血球分离术）、细胞生产（治疗性克隆、体外受精、细胞培养、分离）、冷冻保存和扩增/继代培养。按应用领域划分，该市场可分为肌肉骨骼疾病、伤口/手术、发炎/自体免疫疾病、心血管疾病、神经系统疾病及其他。依最终用户划分，市场可分为医院、专科诊所、学术和研究机构及其他。分析按地区划分：北美、欧洲、亚太、中东和非洲以及拉丁美洲。

全球干细胞治疗市场驱动因素

全球干细胞治疗市场主要得益于政府机构的财政支持和有利的法规结构，从而为该领域的研究和开发创造了有利环境。这种支持促进了细胞研究的各项研究倡议和资金筹措投入。这主要是由于迫切需要针对包括自体免疫、神经系统疾病和心血管疾病在内的各种疾病的创新有效疗法。对生物製造设施等基础设施建设的投资进一步推动了干细胞治疗的发展，增强了推动这一充满前景的医学领域的能力和资源。

限制全球干细胞治疗市场的因素

全球干细胞治疗市场面临许多挑战，主要源自于使用源自人类胚胎的胚胎干细胞所引发的伦理问题。这引发了与可能终止人类生命相关的深刻道德问题，使干细胞研发格局变得复杂。此外，干细胞治疗的监管环境也存在差异，受到不同地区文化和社会价值观的影响。这种不一致不仅阻碍了创新，也为研究人员和投资者带来了不不确定性，最终限制了干细胞疗法在市场上的发展和商业化。

全球干细胞疗法市场趋势

全球干细胞治疗市场正呈现出显着的创新和先进治疗方法研发趋势，各公司都在积极寻求专业人才来推动研究、开发和应用。再生医学领域的突破性进展加速了对具备基因工程、细胞生物学和临床试验管理等专业知识的人才的需求。这一趋势反映了干细胞研究领域投资的不断增长，以及生物技术公司、学术机构和医疗服务提供者之间合作的日益密切。因此，在有望改变多种疾病治疗模式的进步推动下，该市场预计将实现强劲成长。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Smith & Nephew plc（United Kingdom）
Medipost Co. Ltd.（South Korea）
JCR Pharmaceuticals Co., Ltd.（Japan）
Takeda Pharmaceutical Company Limited（Japan）
Anterogen Co., Ltd.（South Korea）
Corestem, Inc.（South Korea）
Pharmicell Co., Ltd（South Korea）
NuVasive, Inc.（United States）
Holostem SRL（Italy）
Orthofix Medical Inc.（United States）
Stempeutics Research Pvt Ltd.（India）
Regrow Biosciences Pvt Ltd.（India）
Healios KK（Japan）
Mesoblast Ltd.（Australia）
BioRestorative Therapies, Inc.（United States）
Pluri Inc.（Israel）
BrainStorm Cell Inc（United States）
Ayrmid Limited（Gamida Cell）（United Kingdom）
Vertex Pharmaceuticals（ViaCyte, Inc.）（United States）
Kangstem Biotech Co., Ltd.（South Korea）

结论与建议

简介目录

Product Code: SQMIG35H2162

Global Stem Cell Therapy market size was valued at USD 369.62 Million in 2024 and is poised to grow from USD 438.74 Million in 2025 to USD 1729.07 Million by 2033, growing at a CAGR of 18.7% in the forecast period (2026-2033).

The global stem cell therapy market is experiencing notable expansion, propelled by the rising incidence of chronic diseases and the adoption of stem cell-based treatments as effective outcome-oriented solutions. This market benefits from increasing regulatory support and a growing consumer demand for regenerative medicine. Notably, cell therapies utilizing Mesenchymal Stem Cells (MSCs) and Induced Pluripotent Stem Cells (iPS) are becoming prominent, with applications emerging across various therapeutic fields such as neurology, cardiology, and musculoskeletal disorders. Nonetheless, significant challenges persist, including the high upfront costs associated with research, clinical trials, and regulatory approvals, alongside technical difficulties in commercialization, which collectively act as substantial barriers to market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Stem Cell Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Stem Cell Therapy Market Segments Analysis

The global stem cell therapy market is segmented into type, therapy, source, route of administration, technology, application, end user, and region. By type, the market is classified into Totipotent Stem Cells, Multipotent Stem Cells, Pluripotent Stem Cells, Unipotent Stem Cells, Others. Depending on therapy, it is divided into Allogeneic Stem Cell Therapy and Autologous Stem Cell Therapy. According to source, the market is categorized into Adult Stem Cells, Embryonic Stem Cells, Mesenchymal Stem Cells (MSCs), and Induced Pluripotent Stem Cells (iPS). Depending on route of administration, it is divided into Intravenous (IV) Infusion, Intraarticular Injection, Intrathecal Injection, Intradermal Injection, Others. By technology, the market is classified into Cell Acquisition (Bone Marrow Harvest, Umbilical Blood Cord, Apheresis), Cell Production (Therapeutic Cloning, In-vitro Fertilization, Cell Culture, Isolation), Cryopreservation, Expansion and Sub-Culture. According to application, the market is categorized into Musculoskeletal Disorders, Wounds & Surgeries, Inflammatory & Autoimmune Diseases, Cardiovascular Diseases, Neurological Disorders, and Others. By end user, the market is classified into Hospitals, Specialty Clinics, Academic & Research Institutes, and Others. Regionally, the market is analyzed across North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

Driver of the Global Stem Cell Therapy Market

The Global Stem Cell Therapy market is significantly driven by financial support from governmental bodies and favorable regulatory frameworks, which create an encouraging environment for research and development in the field. This support has fostered heightened research initiatives and funding opportunities for cellular studies, largely due to the pressing demand for innovative and effective treatment solutions for a variety of conditions, including autoimmune, neurological, and cardiovascular diseases. Such investments in developing infrastructure, like biomanufacturing facilities, further bolster the growth of stem cell therapies, enhancing both the capabilities and resources available for advancing this promising area of medicine.

Restraints in the Global Stem Cell Therapy Market

The global stem cell therapy market faces significant challenges due to ethical concerns surrounding the use of embryonic stem cells, primarily derived from human embryos. This raises profound moral questions related to the potential termination of human life, which complicates the landscape of stem cell research and development. Additionally, the regulatory environment governing stem cell therapies is inconsistent across different regions, influenced by varying cultural and societal attitudes. Such disparities not only stymie innovation but also create uncertainty for researchers and investors, ultimately limiting the progress and commercialization of stem cell therapies in the marketplace.

Market Trends of the Global Stem Cell Therapy Market

The Global Stem Cell Therapy market is experiencing a significant trend towards innovation and the development of advanced therapeutics, prompting companies to seek specialized talent to drive research and application. As breakthroughs in regenerative medicine gain momentum, the demand for skilled professionals with expertise in genetic engineering, cellular biology, and clinical trial management is intensifying. This trend reflects the growing investment in stem cell research and the increasing collaboration between biotech firms, academic institutions, and healthcare providers. Consequently, the market is positioned for robust growth, fueled by advancements that promise to transform treatment paradigms across various medical conditions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Study Analysis
Patent Analysis

Global Stem Cell Therapy Market Size by Type & CAGR (2026-2033)

Market Overview
Totipotent Stem Cells
Multipotent Stem Cells
Pluripotent Stem Cells
Unipotent Stem Cells
Others

Global Stem Cell Therapy Market Size by Therapy & CAGR (2026-2033)

Market Overview
Allogeneic Stem Cell Therapy
Autologous Stem Cell Therapy

Global Stem Cell Therapy Market Size by Source & CAGR (2026-2033)

Market Overview
Adult Stem Cells
Embryonic Stem Cells
Mesenchymal Stem Cells (MSCs)
Induced Pluripotent Stem Cells (iPS)

Global Stem Cell Therapy Market Size by Route of Administration & CAGR (2026-2033)

Market Overview
Intravenous (IV) Infusion
Intraarticular Injection
Intrathecal Injection
Intradermal Injection
Others

Global Stem Cell Therapy Market Size by Technology & CAGR (2026-2033)

Market Overview
Cell Acquisition
- Bone Marrow Harvest
- Umbilical Blood Cord
- Apheresis
Cell Production
- Therapeutic Cloning
- In-vitro Fertilization
- Cell Culture
- Isolation
Cryopreservation
Expansion and Sub-Culture

Global Stem Cell Therapy Market Size by Application & CAGR (2026-2033)

Market Overview
Musculoskeletal Disorders
Wounds & Surgeries
Inflammatory & Autoimmune Diseases
Cardiovascular Diseases
Neurological Disorders
Others

Global Stem Cell Therapy Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Specialty Clinics
Academic & Research Institutes
Others

Global Stem Cell Therapy Market Size & CAGR (2026-2033)

North America (Type, Therapy, Source, Route of Administration, Technology, Application, End User)
- US
- Canada
Europe (Type, Therapy, Source, Route of Administration, Technology, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Therapy, Source, Route of Administration, Technology, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Therapy, Source, Route of Administration, Technology, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Therapy, Source, Route of Administration, Technology, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Smith & Nephew plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medipost Co. Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JCR Pharmaceuticals Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anterogen Co., Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corestem, Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pharmicell Co., Ltd (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NuVasive, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Holostem SRL (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix Medical Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stempeutics Research Pvt Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Regrow Biosciences Pvt Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Healios KK (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mesoblast Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioRestorative Therapies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pluri Inc. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BrainStorm Cell Inc (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ayrmid Limited (Gamida Cell) (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vertex Pharmaceuticals (ViaCyte, Inc.) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kangstem Biotech Co., Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments